ICU Medical (NASDAQ:ICUI) Reaches New 12-Month Low - Here's Why

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $132.39 and last traded at $136.59, with a volume of 221190 shares changing hands. The stock had previously closed at $137.27.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Friday. KeyCorp reduced their price target on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Raymond James set a $97.00 price objective on shares of ICU Medical in a report on Wednesday, March 12th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $162.67.

ICU Medical Stock Up 3.4 %

The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The stock has a market cap of $3.49 billion, a PE ratio of -30.99 and a beta of 0.86. The business has a 50-day moving average price of $141.61 and a 200-day moving average price of $156.60.

Hedge Funds Weigh In On ICU Medical

A number of hedge funds have recently made changes to their positions in ICUI. Arizona State Retirement System increased its holdings in shares of ICU Medical by 1.0% in the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock valued at $1,044,000 after purchasing an additional 65 shares during the last quarter. Huntington National Bank grew its position in ICU Medical by 6.2% in the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock valued at $218,000 after acquiring an additional 82 shares in the last quarter. Equitable Trust Co. increased its stake in ICU Medical by 1.6% during the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after buying an additional 84 shares during the period. Xponance Inc. increased its position in shares of ICU Medical by 5.3% during the first quarter. Xponance Inc. now owns 1,714 shares of the medical instruments supplier's stock worth $238,000 after acquiring an additional 86 shares during the period. Finally, LPL Financial LLC boosted its holdings in ICU Medical by 2.0% in the fourth quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock valued at $747,000 after purchasing an additional 93 shares during the period. Institutional investors and hedge funds own 96.10% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.